Macro-complexes and possibilities of their detection
Authors:
J. Komrsková 1,2; J. Franeková 1,2; A. Jabor 1,2
Authors place of work:
Pracoviště laboratorních metod, Institut klinické a experimentální medicíny, Praha
1; 3. lékařská fakulta, Univerzita Karlova, Praha
2
Published in the journal:
Klin. Biochem. Metab., 27, 2019, No. 4, p. 172-176
Summary
Objective: Presentation of current knowledge of clinical issues of macro-complexes and possibilities of their detection.
Design: literature review
Settings: Institute for Clinical and Experimental Medicine
Material and Methods: Clinical problems of macro-complexes are evaluated on the basis of literature review. The types of macro-complexes, their association with diseases and frequency of occurrence are listed. Furthermore, current possibilities of detection of macro-complexes are reported.
Results: Macro-complexes are most often formed by binding of enzyme and immunoglobulin G (IgG). This may be either non-specific binding or binding with specific autoantibodies circulating in the serum. Macro-amylase was the first described macro-enzyme, which is reported most frequently together with macro-AST. Due to the increasing sensitivity of laboratory methods, macro-troponins and other macro-proteins are currently captured. The prevalence of macro-complexes in serum is not fully known, it varies in each particular macro-complex in studies, and is reported from 0.5% (macro-TSH) to 20.4% (macro-troponin). The presence of the macro-complex is considered to be a benign finding that occurs both in completely healthy individuals without symptoms and in association with autoimmune (especially systemic lupus erythematosus) and other diseases (malignancies, inflammatory diseases, etc.).
Conclusion: In case of persistent isolated increase in enzyme or protein without proven causes, attention should be paid to the possibility of the presence of the macro-complex in the patient’s serum or other possible interferences (presence of heterophilic antibodies, rheumatoid factor, hemolysis, etc.). Effective communication between the clinician and the laboratory is therefore essential for the discrepancy of results both for the capture and detection of suspected macro-complexes and for the detection of other interfering substances in the serum sample.
Keywords:
macro-complexes – macro-enzymes – macro-proteins
Zdroje
1. Thomas, L. Clinical Laboratory Diagnostics: Use and Assessment of Clinical Laboratory Results. Frankfurt am Main: TH-Books, 1998, 1527 s. ISBN 3-98052154-0.
2. Horie, Y., Chiba, M., Iizuka, M., Watanabe, H., Masamune, O., Kakizaki, Y. A case of ulcerative colitis with positive alkaline phosphatase-linked immunoglobulin. Nihon Shokakibyo Gakkai Zasshi. 1989, 86(6), p. 1326-1330.
3. Pesce, M. A. The CK and LD macroenzymes. Lab Ma-nagement. 1984, 29, p. 41.
4. Wilding, P., Cooke, W. T., Nicholson, G. I. Globulin bound amylase: A Cause of Persistently Elevated Levels in Serum. Ann Intern Med. 1964, 60(6), p. 1053-1059.
5. Stasia, M. J., Surla, A., Renversez, J. C., Pene, F., Morel-Femelez, A., Morel, F. Aspartate aminotransferase macroenzyme complex in serum identified and characterized. Clin Chem. 1994, 40(7 Pt 1), p. 1340-3.
6. Krishnamurthy, S., Korenblat, K. M., Scott, M. G. Persistent increase in aspartate aminotransferase in an asymptomatic patient. Clin Chem. 2009, 55(8), p. 1573-5.
7. Davidson, D. F., Watson, D. J. Macroenzyme detection by polyethylene glycol precipitation. Ann Clin Biochem, 2003, 40 (5), p. 514-520.
8. Liu, C. Y., Lai, Y. C., Wu, Y. C., Tzeng, CH., Lee, S. D. Macroenzyme creatine kinase in the era of modern laboratory medicine. J Chin Med Assoc. 2010, 73(1), p. 35-9.
9. Perry, C., Peretz, H., Ben-Tal, O., Eldor, A. Highly elevated lactate dehydrogenase level in a healthy individual: a case of macro-LDH. Am J Hematol. 1997, 55(1), p. 39-40.
10. Cervinski, M. A., Lee, H. K., Martin, I. W., Gavrilov, D. K. A macro-enzyme cause of an isolated increase of alkaline phosphatase. Clin Chim Acta. 2015, 440, p. 169-171.
11. Stein, W., Bohner, J., Bahlinger, M. Macro-lipase a new member of the family of immunoglobulin-linked enzymes. J Clin Chem Clin Biochem. 1987, 25(12), p. 837-843.
12. Sturk, A., Sanders, G. T. Macro enzymes: prevalence, composition, detection and clinical relevance. J Clin Chem Clin Biochem. 1990, 28(2), p. 65-81.
13. Warner, J. V., Marshall, G. A. High incidence of macrotroponin I with a high-sensitivity troponin I assay. Clin Chem lab Med. 2016, 54(11), p. 1821-1829.
14. Hattori, N., Inagaki, C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. J Clin Endocrinol Metab. 1997, 82(9), p. 3107-3110.
15. Loh, T. P., Kao, S. L., Halsall, D. J., et al. Macro-thyrotropin: a case report and review of literature. J Clin Endocrinol Metab. 2012, 98, p. 1823-1828.
16. Kammeraat, C., de Jong, J. A. Macroamylase not always evidenced by a broad band in agarose gel electrophoresis. Clin Chem. 1985, 31(6), p. 1078.
17. Nagamine, M., Okochi, K. Complexes of immunoglobulins A and G with aspartate aminotransferase isoenzymes in serum. Clin Chem. 1983, 29(2), p. 379-81.
18. Komrsková, J., Hejlová, I., Kubíček, Z., Bartošová, K., Jabor, A., Franeková, J. Průkaz makro AST v běžné klinické praxi. Klin Biochem Metab, 2015, 23(44), No. 4, p. 171–174.
19. Hejlová, I., Komrsková, J., Sticová, E., Trunečka, P., Špičák, J., Franeková, J. Makro-AST jako příčina izolované chronicky zvýšené aktivity AST – popis dvou případů. Gastroent Hepatol. 2016, 70(2), p. 138-140.
20. Brožová, T., David, J., Komrsková, J., Votava, F. Makro AST jako příčina asymptomatické elevace aspartátaminotransferázy. Československá pediatrie. 2018, 73(3), p. 146-148.
21. Galasso, P. J., Litin, S. C., O’Brien, J. F. The macroenzymes: a clinical review. Mayo Clin Proc. 1993, 68(4), p. 349-354.
22. Delanghe, J., De Buyzere, M., De Scheerder, I., Vanderborght, J., Wieme, R. Macro-lactate dehydrogenase in serum after acute myocardial infarction (letter). Clin. Chem, 1987, 33, p. 1103-1104.
23. Pudek, M. R., Jacobson, B. E. Falsely negative Laboratory Diagnosis for Myocardial Infarction Owing to the Concurrent Presence of Macro Creatine Kinase and Macro Lactate Dehydrogenase. Clin. Chem. 1982, 28(12), p. 2434-2437.
24. Bodensteiner, J. B. Macro creatine kinase type 1: a cause of spuriously elevated serum creatine kinase associated with leukoencephalopathy in a child. J Child Neurol. 2014, 29(7), p. 973-976.
25. Biewenga, J., Feltkamp, T. E. W. Lactate dehydrogenase (LDH) -IgG3 immunoglobulin complexes in human serum. Clin Chim Acta. 1975, 64, p. 101-116.
26. Owen, M. C., Pike, L. S., George, P. M., Barclay, M. L., Florkowski, C. M. Macro-alkaline phosphatase due to IgG kappa complex: demonstration with polyethylene glycol precipitation and immunofixation. Ann Clin Biochem. 2002, 39(Pt 5), p. 523-525.
27. McTaggart, M. P., Rawson, C., Lawrence, D., et al. Identification of macro-alkaline phosphatase komplex in a patient with inflammantory bowel disease. Ann Clin Biochem. 2012, 49, p. 405-407.
28. Zaman, Z., Van Orshoven, A., Mariën, G., Fevery, J., Blanckaert, N. Simultaneous macroamylasemia and macrolipasemia. Clin Chem. 1994, 40(6), p. 939-942.
29. Taes, Y. E., Louagie, H., Yvergneaux, J. P., De Buyzere, M. L., De Puydt, H., Delanghe, J. R., Lott, J. A. Prolonged hyperlipasemia attributable to a novel type of macrolipase. Clin Chem. 2000, 46(12), p. 2008-2013.
30. Nemesánszky, E., Lott, J. A. Gamma-glutamyl-transferase and its izoenzymes: progress annd problems. Clin Chem. 1985, 31, p. 797-803.
31. Tritos, N. A., Klibanski, A. Prolactin and its Role in Human Reproduction. Physiology, Pathophysiology, and Clinical Management, 2019, p. 58-74.
32. Marek, J. Hyperprolaktinemie v praxi. Interní Med., 2008, 10(12), s. 549-554.
33. Prodan, P., Nandoshvili, E., Webster, C., Shakher, J. Asymptomatic elevated PTH level due to immunoassay interference resulting from Macro-PTH: a case report. Endocrine Abstracts. 2016, 44 CC4 | DOI: 10.1530/endoabs.44.CC4
34. Domanski, O., Maréchaux, S., Forzy, G., Lemahieu, J. M. An unexpected rise in cardiac troponin I in a patient with multiple myeloma. BMJ Case Reports. 2012, doi:10.1136/bcr-2012-006222
35. Wong, S. L., Isserow, S., Pudek, M. Macrotroponin Causing Elevation in Cardiac Troponin I. Can J Cardiol. 2014, 30, p. 956.
36. Lam, L. Identification of Macro Troponin T. Roche User Group Meeting 0850-0910, 2018. [cit. 2019-08-06] Dostupné na WWW https://dialog.roche.com/content/dam/dialog/owp/newzealand/Media/Education/RUG2018/RUG2018_CC_%20Identification_of_Macro_TroponinT.pdf
37. Franeková, J., Bláha, M., Bělohoubek, J., et al. A clinical and laboratory approach used to elucidate discordant results of high-sensitivity troponin T and troponin I. Clin Chim Acta, 2015, 446, p. 128-131.
38. Adamczyk, M., Brashear, R. J., Mattingly, P. G. Circulating cardiac troponin-I autoantibodies in human plasma and serum, Ann N Y Acad Sci. 2009, 1173, p. 67-74.
39. Briani, C., Zaninotto, M., Forni, M., Burra, P. Macroenzymes: too often overlooked (letter). J Hepatology, 2003, 38, p. 119.
Štítky
Clinical biochemistry Nuclear medicine Nutritive therapistČlánok vyšiel v časopise
Clinical Biochemistry and Metabolism
2019 Číslo 4
Najčítanejšie v tomto čísle
- Hypernatremia – Frequency, Causes, Pathobiochemistry, Clinic and Therapy
- Non-specific and ambiguous positive laboratory findings
- Oxysterols - biochemistry and clinical importance
- Macro-complexes and possibilities of their detection